OtherBasic Science (Animal or Phantoms)
Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn and Wolfgang A. Weber
Journal of Nuclear Medicine August 2019, jnumed.119.226993; DOI: https://doi.org/10.2967/jnumed.119.226993
Zohreh Varasteh
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Sarajo Mohanta
2 Institute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Germany;
Stephanie Robu
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Miriam Braeuer
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Yuanfang Li
2 Institute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Germany;
Negar Omidvari
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Geoffrey Topping
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Ting Sun
2 Institute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Germany;
Stephan G. Nekolla
3 Technische Universitaet Muenchen, Germany;
Antonia Richter
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Christian Weber
2 Institute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Germany;
Andreas Habenicht
2 Institute for Cardiovascular Prevention, University Hospital of Ludwig-Maximilians-University, Germany;
Uwe A. Haberkorn
4 University Hospital Heidelberg, Germany
Wolfgang A. Weber
1 Department of Nuclear Medicine, Klinikum rechts der Isar-TUM, Germany;
Article Figures & Data
Additional Files
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue 4
April 1, 2024
Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn, Wolfgang A. Weber
Journal of Nuclear Medicine Aug 2019, jnumed.119.226993; DOI: 10.2967/jnumed.119.226993
Molecular imaging of fibroblast activity after myocardial infarction using a 68Ga-labelled fibroblast activation protein inhibitor FAPI-04
Zohreh Varasteh, Sarajo Mohanta, Stephanie Robu, Miriam Braeuer, Yuanfang Li, Negar Omidvari, Geoffrey Topping, Ting Sun, Stephan G. Nekolla, Antonia Richter, Christian Weber, Andreas Habenicht, Uwe A. Haberkorn, Wolfgang A. Weber
Journal of Nuclear Medicine Aug 2019, jnumed.119.226993; DOI: 10.2967/jnumed.119.226993
Jump to section
Related Articles
Cited By...
- Toward Quantitative Multisite Preclinical Imaging Studies in Acute Myocardial Infarction: Evaluation of the Immune-Fibrosis Axis
- Myocardial Fibrosis: Emerging Target for Cardiac Molecular Imaging and Opportunity for Image-Guided Therapy
- Molecular Imaging Biomarkers in Cardiooncology: A View on Established Technologies and Future Perspectives
- [68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis
- PET imaging of fibroblast activation protein alpha (FAP) detects incipient cardiotoxicity due to anthracycline chemotherapy
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- [68Ga]Ga-FAPI-46 PET for Visualization of Postinfarction Renal Fibrosis
- Molecular Imaging of Myocardial Fibroblast Activation in Patients with Advanced Aortic Stenosis Before Transcatheter Aortic Valve Replacement: A Pilot Study
- Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome
- Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 2: Inflammation, Fibrosis, Thrombosis, Calcification, and Amyloidosis Imaging
- PET/MRI, Part 4: Clinical Applications
- Pitfalls and Common Findings in 68Ga-FAPI PET: A Pictorial Analysis
- Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
- The Latest Advances in Imaging Crosstalk Between the Immune System and Fibrosis in Cardiovascular Disease
- Combination of Forced Diuresis with Additional Late Imaging in 68Ga-PSMA-11 PET/CT: Effects on Lesion Visibility and Radiotracer Uptake
- FAPI-74 PET/CT Using Either 18F-AlF or Cold-Kit 68Ga Labeling: Biodistribution, Radiation Dosimetry, and Tumor Delineation in Lung Cancer Patients
- The Latest Developments in Imaging of Fibroblast Activation Protein
- Targeted PET Imaging of Chemokine Receptor 2-Positive Monocytes and Macrophages in the Injured Heart
- Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
- The Future of Nuclear Medicine Depends on the Quality of Its Research: Researchers at the University of Heidelberg Receive the Award for Best Article of the Year
- The Changing Face of Nuclear Cardiology: Guiding Cardiovascular Care Toward Molecular Medicine
- CARTing Away Cardiac Fibrosis
- FAP: The Next Billion Dollar Nuclear Theranostics Target?